q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

Forty-Seven (47) New Generic Equivalents Added to Medicare Part D formularies in April 2017

Category: Monthly Formulary Changes
Published: May, 03 2017 08:05:11
< Previous
Next >
The April 2017 updates to the Medicare Part D plan formulary data (or drug lists) saw the addition of 47 new generic equivalents (National Drug Codes or NDCs).

In fact, together the April and May 2017 Medicare Part D formulary updates included a total of 49 new generic equivalents (manufacturer, drug, strength, and packaging combinations) representing 25 specific generic drugs.

The National Drug Code (NDC) uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.

Some interesting additions to the 2017 formularies include:


Generic Drug Equivalent [Brand-Name Drug]

Number of
PDP
Formularies

Number of
MAPD
Formularies
GLYBURIDE 1.25 MG / METFORMIN HYDROCHLORIDE 250 MG ORAL TABLET [Glucovance] 20 145
LOPINAVIR-RITONAVIR 80-20MG/ML [Kaletra] 56 326
ABACAVIR-LAMIVUDINE 600-300 MG [Epzicom] 57 331
AMLODIPINE-OLMESARTAN 10-20 MG [Azor] 31 193
APREPITANT 125 MG CAPSULE [Emend] 50 310
CLINDAMYCIN PHOSPHATE-BENZOYL PEROXIDE 1.2-5% [Benzaclin] 19 127
CLINDAMYCIN-TRETINOIN 1.2%-0.025%
[Veltin, Ziana]		 11 77
DAPTOMYCIN 500 MG VIAL [Cubicin] 53 316
DROSP-EE-LEVOMEF 3-0.02-0.451 [Beyaz, Safyral] 24 128
ETHACRYNIC ACID 25 MG TABLET [Edecrin] 13 109
ETHYNODIOL-ETH ESTRA 1MG-50MCG [ZOVIA] 49 284
EZETIMIBE 10 MG TABLET [Zetia] 28 221
FENOFIBRATE 150 MG CAPSULE [LIPOFEN] 7 105
FLURANDRENOLIDE 0.05% LOTION [Cordran] 7 72
IRBESARTAN 150 MG TABLET [Avapro] 57 330
NILUTAMIDE 150 MG TABLET [Nilandron] 57 327
OLMESARTAN MEDOXOMIL 20 MG TAB [Benicar] 37 218
OLMSRTN-AMLDPN-HCTZ 20-5-12.5 [TRIBENZOR] 35 184
OSELTAMIVIR PHOS 30 MG CAPSULE [Tamiflu] 57 310
PARICALCITOL 1 MCG CAPSULE [Zemplar] 57 317
QUETIAPINE ER 150 MG TABLET [Seroquel] 34 271
RASAGILINE MESYLATE 0.5 MG TABLET [Azilect] 50 311
TELMISARTAN-HCTZ 40-12.5 MG TB [Micardis] 39 249
TOBRAMYCIN 10 MG/ML VIAL
[Bethkis, Tobi, Tobi Podhaler, Tobramycin Sulfate]		 57 325
VALGANCICLOVIR HCL 50 MG/ML [Valcyte] 50 277

The following table details the 47 manufacturer / drug / strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the April 2017 updates. You can click on the NDC or Drug Name below to go to our Q1Medicare.com DrugFinder to see the details of how this drug is handled by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.

April 2017 Generic Medications Added to Medicare Part D
NDC Generic Drug Name Brand-Name Drug
66993048230 ABACAVIR-LAMIVUDINE 600-300 MG [Epzicom]
57664077383 AMLODIPINE-OLMESARTAN 10-20 MG [Azor]
57664077583 AMLODIPINE-OLMESARTAN 10-40 MG [Azor]
57664077283 AMLODIPINE-OLMESARTAN 5-20 MG [Azor]
57664077483 AMLODIPINE-OLMESARTAN 5-40 MG [Azor]
00781232368 APREPITANT 125 MG CAPSULE [Emend]
00781406336 APREPITANT 125-80-80 MG PACK [Emend]
00781232151 APREPITANT 40 MG CAPSULE [Emend]
00781232268 APREPITANT 80 MG CAPSULE [Emend]
00781716119 CLINDAMYCIN PHOSPHATE-BENZOYL PEROXIDE 1.2-5% [Benzaclin]
00472179060 CLINDAMYCIN-TRETINOIN 1.2%-0.025% [Veltin, Ziana]
00703012501 DAPTOMYCIN 500 MG VIAL [Cubicin]
00781407515 DROSP-EE-LEVOMEF 3-0.02-0.451 [Beyaz, Safyral]
68682001110 ETHACRYNIC ACID 25 MG TABLET [Edecrin]
00378730653 ETHYNODIOL-ETH ESTRA 1MG-50MCG [ZOVIA]
49884022809 EZETIMIBE 10 MG TABLET [Zetia]
62559046190 FENOFIBRATE 150 MG CAPSULE [LIPOFEN]
62559046090 FENOFIBRATE 50 MG CAPSULE [LIPOFEN]
51672529808 FLURANDRENOLIDE 0.05% LOTION [Cordran]
43547027803 IRBESARTAN 150 MG TABLET [Avapro]
62559017331 NILUTAMIDE 150 MG TABLET [Nilandron]
00378711277 OLMESARTAN MEDOXOMIL 20 MG TAB [Benicar]
00378712493 OLMESARTAN MEDOXOMIL 40 MG TAB [Benicar]
00378701293 OLMESARTAN MEDOXOMIL 5 MG TAB [Benicar]
49884078609 OLMSRTN-AMLDPN-HCTZ 20-5-12.5 [TRIBENZOR]
49884078909 OLMSRTN-AMLDPN-HCTZ 40-10-12.5 [TRIBENZOR]
49884079009 OLMSRTN-AMLDPN-HCTZ 40-10-25MG [TRIBENZOR]
49884078709 OLMSRTN-AMLDPN-HCTZ 40-5-12.5 [TRIBENZOR]
49884078809 OLMSRTN-AMLDPN-HCTZ 40-5-25 MG [TRIBENZOR]
47781046813 OSELTAMIVIR PHOS 30 MG CAPSULE [Tamiflu]
47781046913 OSELTAMIVIR PHOS 45 MG CAPSULE [Tamiflu]
47781047013 OSELTAMIVIR PHOS 75 MG CAPSULE [Tamiflu]
10888500102 PARICALCITOL 1 MCG CAPSULE [Zemplar]
10888500202 PARICALCITOL 2 MCG CAPSULE [Zemplar]
10888500302 PARICALCITOL 4 MCG CAPSULE [Zemplar]
49884080602 QUETIAPINE ER 150 MG TABLET [Seroquel]
49884080702 QUETIAPINE ER 200 MG TABLET [Seroquel]
49884080802 QUETIAPINE ER 300 MG TABLET [Seroquel]
16729009712 QUETIAPINE ER 400 MG TABLET [Seroquel]
49884080502 QUETIAPINE ER 50 MG TABLET [Seroquel]
47781013830 RASAGILINE MESYLATE 0.5 MG TABLET [Azilect]
47781013930 RASAGILINE MESYLATE 1 MG TABLET [Azilect]
13668015930 TELMISARTAN-HCTZ 40-12.5 MG TB [Micardis]
33342012907 TELMISARTAN-HCTZ 80-12.5 MG TB [Micardis]
13668016130 TELMISARTAN-HCTZ 80-25 MG TAB [Micardis]
63323030502 TOBRAMYCIN 10 MG/ML VIAL [Bethkis, Tobi,
Tobi Podhaler,
Tobramycin Sulfate]
00591257920 VALGANCICLOVIR HCL 50 MG/ML [Valcyte]

What Could the Addition of New Generic Drugs Mean to You?

  • You may be able to save money by switching from the brand-name drug to its generic equivalent – with your prescriber’s approval and a new prescription.  Please note, you will need to look carefully at coverage costs as we have found that many 2017 generics are being offered on the same tier as their brand-name equivalent or the generics do not have a significantly lower retail price.  For example, the brand-name Tamiflu (45 mg) may have a retail cost of around $132.16 as a Tier 4 drug (35% co-insurance) and the same plan may now cover the generic equivalent OSELTAMIVIR PHOS 45 MG also as a Tier 4 drug (35% co-insurance).  You can click here to see how your Medicare drug plan is covering these medication.

  • Your brand-name drug may no longer be available if a generic is now available.  From past experience, we may find that many Medicare Part D plans discontinue coverage of a brand-name drug in the months following the introduction of a generic equivalent.  If you have received notice from your Medicare Part D plan that your brand-name medication will be dropped, you should speak with your prescriber to determine if you can take the generic equivalent or if you will need to ask your plan for a formulary exception to continue coverage for the brand-name drug.  You can click for a chart showing the trends in formulary coverage for some of the most popular Medicare drugs and their generic equivalents.

You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser at FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your service area using our Q1Rx.com.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com


Pets are Family Too!
Use your drug discount card to save on medications for the entire family ‐ including your pets.

» Learn more about savings on Pet Medications
  • No enrollment fee and no limits on usage
  • Everyone in your household can use the same card, including your pets
Your drug discount card is available to you at no cost.


© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.